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Molecular analysis of axonal-intrinsic and
glial-associated co-regulation of axon degeneration
Alejandra Catenaccio1,2, Maica Llavero Hurtado3, Paula Diaz1,2, Douglas J Lamont4, Thomas M Wishart3,5 and Felipe A Court*,1,2
Wallerian degeneration is an active program tightly associated with axonal degeneration, required for axonal regeneration and
functional recovery after nerve damage. Here we provide a functional molecular foundation for our undertstanding of the complex
non-cell autonomous role of glial cells in the regulation of axonal degeneration. To shed light on the complexity of the molecular
machinery governing axonal degeneration we employ a multi-model, unbiased, in vivo approach combining morphological
assesment and quantitative proteomics with in silico-based higher order functional clustering to genetically uncouple the intrinsic
and extrinsic processes governing Wallerian degeneration. Highlighting a pivotal role for glial cells in the early stages fragmenting
the axon by a cytokinesis-like process and a cell autonomous stage of axonal disintegration associated to mitochondrial
dysfunction.
Cell Death and Disease (2017) 8, e3166; doi:10.1038/cddis.2017.489; published online 9 November 2017
Axonal degeneration is a common feature of neurodegenera-
tive conditions,1 representing a target for protective interven-
tions. A variety of stimuli can trigger axonal degeneration,
including genetic, toxic and mechanical insults.2 Once axons
are disconnected from their cell bodies, they degenerate
in an orderly fashion. After a delay of 1 to 2 days, they rapidly
disintegrate over 24 hours. Importantly, axonal degeneration
is required for regeneration in the peripheral nervous system.3
To date, much of our knowledge regarding the mechanism
of axonal degeneration and its role in neurodegenerative
conditions has been elucidated through the study of models
with altered neuronal vulnerability. The foremost of these is the
spontaneous neuroprotective mutation Wlds. In Drosophila
and rodents, expressing the product of this mutation is
sufficient to delay axonal degeneration by weeks.4 This
suggests a high degree of evolutionary conservation of the
molecular cascades governing axonal degeneration. Given
this conservation in post-initiation degenerative cascades,
injury-induced degeneration becomes an attractive system
in which to study the processes underpinning axonal
degeneration.2
Such experimental systems can be simplified by examining
the process in isolated neurons in culture in vitro to remove
‘confounding’ factors such as myelinating cells and immune
response mediators. In such preparations, axons degenerate
in a manner similar to axons undergoing Wallerian degenera-
tion in vivo.5 This apparent similarity between in vitro and
in vivo ‘degeneration’ has led to the notion that degeneration
would be entirely mediated by the neuronal axon.6 Therefore,
the participation of other cellular types in this degenerative
process, especially glial cells, has been largely overlooked.
Given that axonal degeneration occurs in a range of conditions
where the initiating insult appears to be extrinsic to the axon
(i.e., immune mediated/demyelinating neuropathies) such
in vitro approaches are not sufficient to identify regulators,
which would be effective in vivo. In addition, the process of
degeneration seems to be under regulation of several intra-
axonal organelles as axonal degeneration is associated with
calcium release from the axonal endoplasmic reticulum7
and activation of the permeability transition pore (mPTP5),
suggesting an orchestration between non-cell autonomous as
well as cell autonomous events.
Glial cells participate in processes which are crucial for the
function of their associated neurons, including but not limited
to energetic metabolism8,9 and the segregation of distinct
axonal domains.10 Glial cells are also proven to contribute to
non-autonomous neuronal loss in the progression of specific
neurodegenerative conditions such as amyotrophic lateral
sclerosis and peripheral demyelinating diseases.11
To establish themost relevant molecular cascades triggered
during the early stages of this dynamic degenerative process
we have combined quantitative proteomicswith morphological
analysis and manipulation of nerves throughout the degen-
erative process in vivo.
Here we demonstrate that axonal injury initiates an early
response in Schwann cells (SCs) resulting in fragmentation of
their associated axons by actin-rich cytoplasmic spirals of SCs
known as Schmidt-Lanterman incisures (SLI). Due to the
molecular and mechanistic alterations we identify in this
process which overlap with cellular cytokinesis, we term this
process ‘axokinesis’. Importantly, interfering with axokinesis
delays the course ofmitochondrial-dependent degeneration of
axons in a non-autonomous manner. Thus, in addition to their
roles in myelin removal and macrophage recruitment in the
later stages of axon degeneration, SCs are also early cellular
participants of axon degeneration.
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By detailing the complexity of this process, regulated by
both neuronal intrinsic and extrinsic factors, we propose that a
holistic in vivo approach will be required to more effectively
control the degenerative process.
Results
To study the process of axonal degeneration in vivo we have
employed an injury induced degenerative paradigm, corre-
sponding to a mechanical injury to the sciatic nerve in vivo.12
This system has many advantages over disease-induced
degenerative models including the control of initiation site and
timing; rapid and reproducible degenerative profile and
reduced molecular noise.
Early axonal fragmentation: the dynamics of myelin-
ovoid formation. In longitudinal sections of uninjured nerves
(Figure 1a), SLI formed by SCs span the depth of the myelin.
In nerves distal to a crush injury, the appearance of these SLI
changes markedly. At 2 and 3 days post-injury (dpi), SLI are
larger and protrude into the axon creating an axonal segment
encapsulated within the inter incisure myelin fragment
(termed an ‘ovoid’; Figure 1a). In transverse sections at 2
dpi, the compact myelin becomes delaminated, the axoplam
disorganizes, mitochondria swell, and by 4 dpi myelin fills the
former axonal space (Figure 1b).
In WT nerves axon fragments are contained within myelin
ovoids: Employing fluorescence microscopy, a precise spa-
tial correspondence between SLI and axonal fragmentation
points is found at 2 dpi (Figure 1c). The distribution of inter-
incisure distance (IID) and myelin ovoid length were compar-
able at 2 dpi (Figures 1d). When compared to IID, the
distribution of axonal segments length (ASL) was shifted to
smaller values, suggesting that these segments are con-
tained within myelin ovoids (Figure 1d), shortening with time
(Figure 1e). The axonal occupancy per fiber was evaluated
as a measurement of axonal disintegration, decreasing with
time after injury (Figure 1f).
The number of macrophages slightly alters at 2 dpi but are
not associated with SLI (Supplementary Figures 1a and b).
Fibroblasts do not increase in number even at 4 dpi, nor they
associate to SLI (Supplementary Figure 1c).
Wlds fragmentation process appears similar to WT but with
delayed onset: Given that Wlds is thought to delay the normal
degenerative process13 we next wanted to establish if this
apparently glial mediated fragmentation process is also
delayed. To this end, sciatic nerves of WT and Wlds mice
were injured and changes evaluated by immunofluorescence
(IF). In WT nerves, axons associated with myelin ovoids
disintegrate with time (Figure 1f), and become almost
completely undetectable by 4 dpi (Figures 1c and f and
Figures 2a–d). In sharp contrast, in Wlds axons this
degenerating process only starts around 15 dpi
(Figures 2a–d), developing a fragmented profile comparable
to those of WT nerves (Figure 2d), and indicating a similar
process of fragmentation, but with a greatly delayed initiation.
These results therefore suggest that before axoplasm
disintegration occurs, axonal injury elicits an early response
from SCs associated with the fragmentation of axons by SLI.
Axonal disintegration is regulated by mPTP activation in
axons and can be genetically uncoupled from SC-
dependent fragmentation. We have previously demon-
strated that genetic inhibition of mPTP activation by cyclo-
philin D (CypD) knockdown delays axonal degeneration
in vitro,5 therefore corresponding to an axonal autonomous
process. At 2 dpi, axonal fragmentation in nerves from
CypD− /− mice was comparable to those of control mice
(Figures 3a and b), as also was the ASL distribution
(Figure 3d). Nevertheless at 4 dpi, axonal desintegration
was strongly inhibited in CypD− /− when compared to WT
nerves (Figures 3c and e). Intraneural administration of
cyclosporin A (CsA), an mPTP inhibitor, produced an effect
comparable to that observed in CypD− /− (Figures 3a–e). In
addition, axonal mitochondrial swelling at 4 dpi – a reporter of
the mPTP activation14 – was strongly inhibited in nerves of
CypD− /−mice or treated with CsA compared to degenerating
nerves from WT mice (at 4 dpi: WT, 655.5±32.6 nm;
CypD− /−, 276,1±23 nm; CsA, 345.5± 21 nm, Po0.01 by
Student’s t-test compared to WT).
We also studied the experimental nerves by electron
microscopy (EM). In control, non-crushed nerves, well-
defined axons were surrounded by an intact myelin sheath
(Supplementary Figure 2). At 4 dpi, few axons remains and
myelin sheets appear disorganized and collapsed
(Supplementary Figure 2). In CypD− /− nerves, axonal degen-
eration at 4 dpi was delayed. Some degenerated myelin were
observed in CypD− /− nerves at 4 dpi, that most likely
corresponded to the poles of ovoids (Supplementary Figure 2).
Together, these data suggest that during the early stages of
Wallerian degeneration axonal fragmentation by SCs is
followed by a mPTP-dependent cell-autonomous process of
axonal disintegration.
Nerve degeneration is perturbed by pharmacological
manipulation of SCs
Axonal fragmentation is delayed by nuclear program inhibi-
tion: The role of SC genetic programs in Wallerian degen-
eration was studied with actinomycin D (ActD), which arrests
transcription.15 Six days after an endoneurial injection of
ActD, the sciatic nerve was crushed proximal to the injection
site and the distal stump was analyzed. In control nerves,
about 90% of fibers were fragmented at 2 dpi and completed
by 4 dpi (Figures 4a and c). After ActD treatment, only 40%
had undergone fragmentation at 2 dpi, and by 4 dpi, there
was still unfragmented axons (Figures 4a and c). In addition,
ActD treatment also affected the disintegration of axons at 4
dpi (Figure 4e). This is evident as a shift in the axonal
segment distribution at both 2 and 4 dpi (Figures 4f and g). In
ActD-treated nerves, EM observation reveals that axonal
degeneration was delayed at 4 dpi (Supplementary Figure 2).
Axonal fragmentation is therefore delayed by days when
transcription in SCs have been turned off, consequently
affecting axonal disintegration.
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Axonal fragmentation is delayed by inhibiting schwann cell
dedifferentiation: After nerve injury, SCs dedifferentiate into a
repair phenotype regulated by the ERK signaling pathway.16
As axonal fragmentation corresponds to an early event after
nerve damage, we wanted to test if this process was
dependent on SC dedifferentiation. We therefore blocked
injury-induced SC dedifferentiation in vivo using the ERK
inhibitor PD0325901. At 2 dpi, the expression of p75NTR,
indicative of SC dedifferentiation, was not detectable following
ERK inhibition (Figures 4b and d). At 2 dpi axonal fragmenta-
tion was delayed (Figures 4c and f) and axonal disintegration
at 4 dpi was also delayed by ERK-inhibition (Figure 4e).
Quantitative proteomic comparison between injured WT
and Wlds nerves reveals cytoskeletal changes correlat-
ing with axonal fragmentation. We employed a quantitative
proteomic approach to elucidate the molecular mechanisms
governing the degenerative program. Nerve extracts were
examined from multiple mouse lines at early stages of injury-
induced degeneration (1 and 2 dpi, Figure 5a and Supple-
mentary Table 1) and morphological correlates (Figures 1 and
2) were used as a filtering guide to determine the contribution of
different processes (see Figure 5b and Methods).
First, we wanted to understand the molecular changes across
the time course of nerve degeneration in WT mice. Figures 5c
and d showaBioLayout generated schematic ofWT time course
data where clusters of co-expressed proteins are grouped in
different colors. A DAVID enrichment analysis of clusters
indicates that co-expressed proteins group into specific func-
tional categories corresponding to cytoskeletal organization,
mitochondria stability/function, and Schwann-cell-mediated
responses (Figure 5d). This broad range of functional categories
further highlights the complexity of the molecular cascades
underpinning the degenerative process.
Figure 1 Dynamics of myelin-ovoid formation and axonal fragmentation. (a) Micrographs of semithin sections from longitudinally oriented nerves from WT mice. Intact
(control) and distal nerves at 2, 3 and 4 days post injury (dpi) are shown. In control nerves, axons are clearly visible (arrows) and SLI are distinguishable (arrowheads). At 2 dpi
axons appears discontinuous and myelin ovoids start to develop. At 3 dpi myelin ovoids encasing axonal segments are clearly identified (black asterisks) and at 4 dpi only myelin
debris are distinguish (white asterisks). Scale bar, 50 μm. (b) Electron micrograph from transverse sections of intact nerves (control) showing intact myelins (arrowhead) around
axons (arrow). At 2 dpi the myelin is disorganized (white asterisk) and the axoplam is less defined (black asterisk) and by 4 dpi myelin sheaths are collapsed and axons
degenerated. Scale bar, 5 μm. (c) Teased fibers from Thy1-YFP mice stained for actin with rhodamine-conjugated phalloidin (red) in the left panels and immunostained against
myelin basic protein (MBP, red) in the right panels. At 2 dpi, axons (green) appear fragmented and encased in a myelin ovoid and by 4 dpi axonal fragments are significantly
reduced in size. Scale bar, 20 μm. (d) Frequency distribution of inter incisure distance (IID), myelin ovoids length (MOL) and axonal segment length (ASL) measured from teased
fibers at 2 dpi from WT mice. Color-coded arrows indicate the mean value in each set of data (n= 3 mice per group, between 150 and 250 fibers were analyzed for IID, MOL and
ASL; *Po0.05 by Student’s t-test compared with 2 dpi vehicle). (e) ASL distribution at 2, 3 and 4 dpi A significant shift toward lower values takes place with time (n= 3 per group;
*Po0.05 by one-way ANOVA plus Bonferroni post hoc test; error bars indicate S.E.M.). (f) Percentage of axonal occupancy per fiber (Ax. Occ/Fib.) measured from teased fibers
(n= 3 mice per group, 25 fibers per group; *Po0.05 by Student’s t-test compared with control or 3 dpi; error bars indicate S.E.M.)
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In-silico analysis at 1 dpi highlights ROCK as a potential focal
regulator of early molecular cascades: After characterizing
the molecular changes taking place in WTs we next wanted
to identify factors associated with axonal fragmentation.
Further filtering was applied to enrich for proteins related to
the fragmentation mechanisms based on the differential
degenerative responses of the mutant mouse nerves
analysed. A total of 154 proteins were selected for in silico
processing as they presented conserved protein expression
between WT and CypD− /−, but differed to Wlds at 1 dpi
(Supplementary Figure 3a, Figures 6a and b and
Supplementary Table 2).
Enrichment analysis of these candidates was carried out to
identify which gross functions may be over represented in this
group. DAVID identified functional annotations related to
cytoskeletal regulation, inflammatory responses, and protein
translation (Figure 6c). Knowing that there is no infiltration of
macrophages at 1 dpi,17,18 the molecular machinery identified
as associating with inflammatory responses and protein
translation pathways are more likely to be associated with
SC activation following nerve damage.
Next, pathway analysis was carried out to identify specific
cascades correlating with axonal fragmentation. For this,
Ingenuity Pathway Analysis software (IPA) (Ingenuity
Systems, Inc., Redwood City, CA, USA) was employed to
compare differentially expressed proteins between WT and
Wlds mice at 1 dpi. The main altered pathways correlated with
the enrichment analysis (Figure 6c), highlighting again that
cytoskeletal regulatory cascades are prominently perturbed
(Figures 6d and e). Specifically, cytoskeletal regulatory path-
ways are predicted to be activated in WT nerves, but inhibited
in Wlds nerves (Figures 6d and e). ‘Actin cytoskeletal
signaling’, displayed in Figures 6f and g highlights the
molecular changes associated with the activation of ROCK
and myosin pathways regulating cytoskeletal reorganization.
Profilin and ARP2/3 were also upregulated in WT nerves
leading to actin polymerization (Supplementary Figure 4 and
Supplementary Figure 5), while in contrast, the same path-
ways inWlds appear to be inactivated with ROCKdescribed as
inhibited, thereby reducing actin polymerization and cytoske-
leton reorganizational processes in Wlds nerves.
Other inflammatory-like response pathways related to the
SC were detected. This correlates with the previous DAVID
enrichment analysis as highly prominent in WT and not
activated in Wlds (Supplementary Figure 6).
This combined proteomic and bioinformatics analysis of WT
and Wlds peripheral nerves at 1 dpi therefore implicates
cytoskeletal signaling pathways as potential regulators of
axonal fragmentation.
Axonal fragmentation by SCs operates using a
cytokinesis-like process
Actin polymerization is required for axonal fragmentation but
not disintegration: Our proteomic analysis comparing WT
versus Wlds mice, revealed major changes associated with
cytoskeleton remodeling. As Schwann cell SLI are actin-rich
structures,19 we explore whether actin dynamics were
required for axonal fragmentation. To this end, we crushed
WT sciatic nerves and injected Cytochalasin-D (CytD, a drug
that inhibits actin polymerization) distal to the crush site. In
CytD-treated fibers, axonal fragmentation was greatly
reduced at 2 dpi (Figures 7a–d). At 4 dpi, the percentage of
fragmented fibers was comparable between vehicle and
CytD-treated nerves (Figure 7b), but axonal desintegration
was delayed by CytD treatment (Figures 7c and e). This
observation supports the proteomic data above.
Figure 2 Axonal fragmentation and disintegration is delayed in Wlds mice. (a) Teased fibers from WT mice sciatic nerves immunostained for neurofilament (Nf-H, green) and
stained for actin filaments using phalloidin (red). At 4 dpi, Wlds mice look like an uninjured nerve, but fragmentation began at 15 dpi Scale bar, 20 μm. (b) Quantification of the
percentage of unfragmented fibers (intact fibers) from teased fibers as shown in (a). In Wlds there are not fragmented fibers at 4 dpi compared with WT mice, where all the fibers
are fragmented at this time. At 15 dpi, half of the fibers are still intact in Wlds. (n= 3 mice per group; between 80 and 100 fibers per group). (c) Percentage of axonal occupancy per
fiber (Ax. Occ/Fib.) measured from teased fibers in WT and Wlds nerves. At 15 dpi start the disintegration of axons in Wlds (n= 3 mice per group; 30 fibers per group were
analyzed). (d) ASL distribution at 2 and 4 dpi from WTand 15 dpi from Wlds. Color-coded arrows indicate the mean value in each set of data (n= 3 mice per group; between 90
and 120 ALS were measured per group; *Po0.05 by Student’s t-test compared with 2 or 4 dpi WT)
Intrinsic and extrinsic mechanisms for axonal degeneration
A Catenaccio et al
4
Cell Death and Disease
Non muscle myosin II is required for axonal fragmentation
and subsequent disintegration: Axonal fragmentation by SLI
appears to be a process of actin-dependent constriction of
the myelin sheath and axonal fragmentation, similar to the
actomyosin contractile ring during cytokinesis.20 Cytokinesis
involves two major scaffolds proteins: septins, that binds
myosin II and anillin that links F-actin to the plasma
membrane.21 In a control nerve, Myosin II is present in SLI
and accumulates in ovoids tips after injury (Supplementary
Figure 7). To explore whether axonal fragmentation uses
similar molecular mechanisms as cytokinesis, we crushed
nerves and inhibited non-muscle myosin II with Blebbistatin
(Blebb). After myosin II inhibition we observed a significant
reduction in fragmentation at 2 dpi (Figures 7a–d), and axonal
disintegration was inhibited at 2 and 4 dpi (Figure 7c). EM
observation reveals that at 4 dpi, Wallerian degeneration was
delayed by Blebbistatin treatment (Supplementary Figure 2).
Anillin is required for axonal fragmentation by SCs: Other
important molecular players in cytokinesis are septin 2 and
anillin. Septin 2 has been observed at SC nodes of Ranvier,
Cajal Bands and SLI.22 In control conditions, we observed
anillin expression in the perinuclear region of SCs and along
Cajal Bands (Figures 8a and b). At 2 dpi, anillin was
present in the nucleus and at the poles of the ovoids
(Figures 8a and b), a change in distribution analogous to the
one that takes place during cytokinesis.23 We used an
shRNA strategy to deplete anillin from SCs in vivo by local
nerve electroporation (see Materials and Methods). This
procedure significantly decreases anillin expression in SCs
(Figures 8c and d). We then assessed the fragmented fibers
in nerves electroporated with a scramble or anillin shRNA at
2 dpi using a fluorescent reporter for electroporated SCs.
In SCs treated with the scramble shRNA, non-fragmented
axons were o20% at 2 dpi whereas treatment with
Figure 3 Axonal fragmentation by SC is mPTP-independent. (a) Teased fibers from WT, CypD− /− and WT nerves injected with Cyclosporine A (CsA, 5 μM) immunostained
for neurofilament (Nf-H, green) and stained for actin filaments using phalloidin (red). At 4 dpi, axonal desintegration in CypD− /− or CsA-treated nerves is inhibited compared to
WT nerves. Axonal fragmentation is not altered by the genetic or pharmacological interventions. Scale bar, 20 μm. (b) Quantification of the percentage of unfragmented fibers
(intact fibers) from teased fibers as shown in a. There are no differences at 2 or 4 dpi in the percentage of fragmented fibers in CypD− /− or CsA nerves (n= 3 mice per group; 70
fibers per group; *Po0.05 by Student’s t-test compared with 2 or 4 dpi vehicle; error bars indicate S.E.M.). (c) Percentage of axonal occupancy per fiber (Ax. Occ/Fib.) measured
from teased fibers in WT, CypD− /− mice and CsA-injected nerves. At 4 dpi, the disintegration of axons is significantly inhibited in both cases (n= 3 mice per group; 25 fibers per
group; *Po0.05 by Student’s t-test compared with 2 or 4 dpi vehicle; error bars indicate S.E.M.). (d and e) ASL distribution at 2 and 4 dpi from WT, CypD− /− and CsA-injected
nerves. At 2 dpi all conditions are comparable, but at 4 dpi CypD− /− and CsA-injected nerves have an ASL distribution shifted to higher values. Color-coded arrows indicate the
mean value in each set of data (n= 3 mice per group; between 80 and 180 ASL were analyzed per group; *Po0.05 by Student’s t-test compared with 2 or 4 dpi vehicle)
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anillin-shRNA resulted in a three-fold inhibition of axonal
fragmentation by SCs (Figures 8e and f).
Axonal fragmentation does not coincide with SC proliferation:
We next assessed whether this cytokinesis-like mechanism
of axonal fragmentation was dissociated from Schwann cell
proliferation, a process that usually takes place at 3 to 4 dpi in
WT nerves.24 To this end, we analyzed the expression and
localization of the protein Ki-67 which translocates into the
nuclei of dividing cells (reporter for G1 to M phase transition).
Localization of Ki-67 was perinuclear at 2 dpi and nuclear at
4 dpi (Figures 8g and h). In addition, Western blot analysis
of Cdc2 expression, a protein associated to G2/M phases,
was undetected at 2 dpi, and strongly upregulated at 7 dpi
(Figure 8i). Together, this data suggest that axonal fragmen-
tation by Schwann cells is not associated to Schwann cell
proliferation after nerve injury.
ROCK activity is required for axonal fragmentation: During
cytokinesis, phosphorylation of the myosin related light chain
(MRLC) by ROCK regulates the interaction of actin and
myosin, leading to the formation of the contractile ring.25
Therefore, we pharmacologically inhibited the kinase function
of ROCK in vivo. To this end, the ROCK inhibitor Y-27632 was
injected into the nerve and crushed proximal to the injected
region. At 2 dpi, axonal fragmentation was strongly inhibited
by Y-27632 compared to vehicle injected and crushed nerves
(Figures 9a–e). In addition, both at 2 and 4 dpi, axonal
Figure 4 Schwann cells dedifferentiation is required for axonal fragmentation. (a) Teased fibers from WT sciatic nerves immunostained for neurofilament (Nf-H, green) and
stained for actin filaments using phalloidin (red). Both Actinomycin D (ActD, 0.2 μg/μl) and PD 0325901 (PD, 2 μM) treatments inhibits axonal fragmentation at 2 dpi and axonal
disintegration at 4 dpi Scale bar, 20 μm. (b) Teased fibers from vehicle or PD 0325901 (PD, 2 μM) injected nerves, in light contrast microscopy (Bright Field, BF) immunostained
with p75NTR (green) and nuclear staining (Dapi) from control nerves and at 2 and 4 dpi In non-injured nerves (control and PD-pretreatment), Schwann cells (SC) are negative for
the differentiated marker p75. In control nerves, SC express p75 at 2 and 4 dpi Injured-induced p75 expression is inhibited by PD treatment. Scale bar, 20 μm. (c) Quantification of
the percentage of unfragmented fibers (intact fibers) after each treatment from teased fibers as shown in (a). At 2 dpi both ActD and PD treatments significantly inhibit fiber
fragmentation, while at 4 dpi, only ActD-treated nerves still have a significantly number of intact fibers (n= 3 mice per group; between 60 and 80 fibers per group were counted;
*Po0.05 by Student’s t-test compared with 2 or 4 dpi vehicle; error bars indicate S.E.M.). (e) Percentage of axonal occupancy per fiber (Ax. Occ/Fib.) measured from teased
fibers in vehicle injected nerves and after ActD and PD injection. At 4 dpi, the disintegration of axons is significantly inhibited after drug treatments (n= 3 mice per group; 25 fibers
per group; *Po0.05 by Student’s t-test compared with 2 or 4 dpi vehicle; error bars indicate S.E.M.). (d) Quantification of the proportion of p75NTR-positive and -negative
expressing fibers (p75+ or p75-) from teased fibers as shown in b. In non-injured fibers, all Schwann cells are p75-. At 2 dpi most Vehicle-injected fibers become p75+ (80%) and all
of them express p75 at 4 dpi In PD-injected nerves, p75 expression is highly inhibited at 2 dpi (13%) and also at 4 dpi (60%), being statistically different from their controls (n= 3
mice per group; between 30 and 50 fibers were analyzed per group; *Po0.05 by Student’s t-test compared with 2 or 4 dpi vehicle). (f and g) ASL distribution at 2 and 4 dpi from
vehicle, ActD and PD-injected nerves. Drug treatments inhibit the reduction of ASL after injury. Color-coded arrows indicate the mean value in each set of data (n= 3 mice per
group; between 90 and 130 ASL per group; *Po0.05 by Student’s t-test compared with 2 or 4 dpi vehicle)
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occupancy and axonal segment length were significantly
higher in Y-27632-injected nerves compared to vehicle-
treated ones (Figures 9c–e). Importantly, MRLC phosphor-
ylation was detected at early time points after nerve injury by
Western blot (Figure 9f). This is consistent with the predicted
regulators identified by our proteomic experiments.
Axonal fragmentation in vitro occurs independently of SC
mechanisms identified above: As in vivo injections targets
Schwann cells and axons, we tested the effect of all used
drugs in axons devoid of Schwann cells in vitro
(Supplementary Figure 8a). In all cases, mechanically
induced axonal degeneration was not modified by ActD,
PD0325901, CytD, Blebb or Y-27632 (Supplementary
Figures 8b and c), suggesting that in vivo these drugs have
a direct effect over Schwann cells that impact the progression
of axonal fragmentation.
Axonal fragmentation by SCs is independent of mito-
chondrial dysfunction in the axonal compartment. The
axon has internal programs for self-destruction that involve
mitochondria, in particular the activation of the mPTP,5
triggered by release of ER-derived calcium, leading to ROS
production, and secondary activation of proteases.4,13 Since
SCs fragments the axon before its disintegration, we studied
the relationship between axonal fragmentation and the
activation of the axonal destruction cascade by analyzing
the CypD− /−, in which the activation of the mPTP is
inhibited.26
Axonal-dependent degenerative processes correlate with
perturbations in 3 metabolic cascades: In order to elucidate
the mechanisms related to mitochondrial-dependent degen-
eration in axons, we employed a variation on the previous
described proteomic filtering strategy (Figure 10a). We
focused on 2 dpi as axonal disintegration occurs after
fragmentation has already begun (Figures 1 and 2). We
identified 190 proteins differentially expressed between
WT and CypD− /− mice at 2 dpi and overlapping with
mitochondrial clustering (Figures 5c and d, Figure 10b,
Supplementary Figure 3, and Supplementary Table 3).
Figure 5 Temporal profiling of the molecular events underpinning injury induced nerve degeneration. (a) Workflow of proteomic analysis and processing of data. (b) Table
illustrating expected morphological hallmarks which can be used as a filtering guide for proteomic data throughout the time-course examined. (c) BioLayout expression analysis
allows a 3D representation of the molecular alterations occurring throughout the time course of WT degeneration. Each sphere represents an individual protein and its color and
proximity to its neighbor indicates the similarity in protein expression (through time). Clusters (groupings of proteins delineated by color) can be further analyzed for cell type or
functional association with other in silico tools such as DAVID thereby allowing the data to be broken down into more manageable groupings (see Materials and Methods).
Example trends and functional categorizations can be seen in (d). The molecular response mapping through axonal degeneration correlated with morphological analysis can be
used to elucidate relative contribution of specific cell types and organelles
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A DAVID enrichment analysis highlighted pathways
related to mitochondria oxidative and metabolic cascades
such as the TCA cycle, glucose or fatty acid metabolism
(Figure 10c). Next, IPA analysis confirmed the perturbation of
multiple canonical pathways including mitochondrial
dysfuction, oxidative phosphorylation, TCA and fatty acid
oxidation – i.e., perturbation of normal mitochondrial cascades
(Figure 10d).
Constituents from all the mitochondrial inner membrane
complexes are differentially expressed in CypD nerves at 2
dpi: In terms of oxidative phosphorylation there is a trend
toward modest downregulation of constituents from complex
I, III and IV in WT nerves (Figure 10e), which contrast to a
strong downregulation of members from all five mitochondrial
inner membrane complexes in CypD− /−, specially complex
IV. Interestingly, complex IV is responsible for the release of
cytochrome c – a process that has been reported to be
blocked in CypD− /−.27 Importantly, reduction in mitochondrial
complex activity, including IV, has been associated with a
reduction in ROS production,28 an important factor in axonal
degeneration.12
Pathway-based predictions identify specific metabolic factors
as potential regulators for the identified pertubations in CypD
degenerating nerves: An analysis for potential upstream
regulators highlighted the inhibition of IGF-1, insulin and
restriction of metabolic cascades (that is, fatty acids and lipid
processing) in CypD− /− relative to WT expression levels
(Figures 10f and g, respectively) and this has previously been
described as contributing to axonal neuroprotection.12
This combined proteomic and bioinformatic analysis of
WT and CypD− /−peripheral nerves at 2 dpi therefore
implicate specific mitochondrial candidates as mediators of
axonal-dependent disintegration, suggesting that axonal
fragmentation and disintegration corresponds to dissectible
degenerating pathways in the glia-axonal unit.
Discussion
Axon degeneration can be initiated by a broad range of
triggers including, but not limited to injury, toxic and genetic
insults, and is an important early event in many pathological
conditions.29,30 Crucially, effective axonal degeneration is
essential for subsequent regeneration and functional recovery
after nerve damage.31 Yet, despite the importance of axon
Figure 6 Bioinformatic analysis of proteomic data at 1 dpi reveals disruption of cytoskeletal related cascades. (a) Table illustrating expected morphological hallmarks that can be
used as a filtering guide at 1 dpi (b) Heat map highlighting expression trends following filtering criteria at 1 dpi, that is, similar trends betweenWTand CypD − /− but different in Wlds.
(c) DAVID enrichment analysis of candidates following filtering highlights three main categories; cytoskeletal organization, inflammatory responses and protein translation which
correlate with the known structural alterations present in WT nerves time-course analysis (Figures 4c and d). (d and e) Canonical pathway comparison betweenWTandWlds filtered
candidates at 1 dpi highlights perturbations in cytoskeletal maintenance and inflammatory responses. Canonical pathways are ranked according to P value and the potential
activation or suppression of that pathway is indicated by color (see Materials and Methods section – IPA prediction tools). Note that pathways such as acute phase response are
activated in WT nerves but inhibited in Wlds. (f and g) Schematic representations of the actin cytoskeleton signaling cascade at 1 dpi and its expression/activation in WTand Wlds
nerves (respectively). Note that candidates such as ROCK, PFN, myosin and ARP are upregulated in WT promoting cytoskeletal re-organization relative to Wlds nerves
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degeneration in injury, disease and regeneration, very little is
known about the factors that govern the process.
Here we have attempted to address this by taking a novel
multi-model in vivo approach, which combined morphological
assesment and quantitative proteomics alongside in silico-
based higher order functional clustering.
Mechanistically, we have found that after nerve injury, SCs
fragment the axon by a mechanism analogous to cytokinesis
which we term ‘axokinesis’ (Figures 7 and 8 and
Supplementary Figure 9). Interfering with axokinesis affects
the course of axonal disintegration in a non-autonomous way.
Based on our results, we propose that the ERK cascade –
critical for SC dedifferentiation16 – is the controlling program
involved in axonal fragmentation. Importantly, delayed axonal
degeneration of Wlds axons is followed by delayed SC-
dependent fragmentation, suggesting that an axonal autono-
mous role of the Wlds protein may delay the intercellular
signaling event that instructs SCs to dedifferentiate and
fragment the axon. Studies on Wallerian degeneration are
commonly performed from 4 dpi onwards, when axons are
almost completely disintegrated and macrophages have
started to invade the damaged nerve. By focusing on early
time points after damage we report the identification of this
novel process of axokinesis that regulates axonal-
autonomous mechanisms of axonal degeneration.
A comparative analysis between WT and Wlds revealed
cytoskeletal-signaling perturbations correlating with axonal
fragmentation processes taking place between 1 and 2 dpi
(Figure 6) highlighting differential expression of key actin
dynamic candidates activated inWT nerves during fragmenta-
tion and inactivated in its absence in the Wlds. Actin, myosin,
anillin and ROCK are all instrumental in axonal fragmentation,
since the interference of any of these actors by genetic or
pharmacological means affects axonal fragmentation.
Figure 7 Axonal fragmentation is dependent on actin and myosin dynamics. (a) Teased fibers from WT mice sciatic nerves immunostained for neurofilament (Nf-H, green)
and stained for actin filaments using phalloidin (red). Both Cytochalasin D (CytD, 2 μg/ml) and Blebbistatin (Blebb, 500 μM) treatments inhibits axonal fragmentation at 2 dpi and
axonal disintegration at 4 dpi Scale bar, 20 μm. (b) Quantification of the percentage of unfragmented fibers (intact fibers) after each treatment from teased fibers as shown in (a).
Only at 2 dpi, both CytD and Blebb treatment significantly inhibit fiber fragmentation (n= 3 mice per group; between 80 and 100 fibers per group; *Po0.05 by Student’s t-test
compared with 2 or 4 dpi vehicle; error bars indicate S.E.M.). (c) Percentage of axonal occupancy per fiber (Ax. Occ/Fib.) measured from teased fibers in vehicle injected nerves
and after CytD and Blebb injection. At 4 dpi, the disintegration of axons is significantly inhibited after drug treatments (n= 3 mice per group; 30 fibers per group were analyzed;
*Po0.05 by Student’s t-test compared with 2 or 4 dpi vehicle; error bars indicate S.E.M.). (d and e) ASL distribution at 2 and 4 dpi from vehicle, CytD and Blebb-injected nerves.
Drug treatments inhibit the reduction of ASL after injury. Color-coded arrows indicate the mean value in each set of data (n= 3 mice per group; between 90 and 120 ALS were
measured per group; *Po0.05 by Student’s t-test compared with 2 or 4 dpi vehicle)
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We conclude that SC participates actively in early steps of
the disintegration of the axoplasm. That is, the axon has its
own destruction mechanisms but SC can speed them up. Our
comparative proteomic and bioinformatics approach examin-
ing CypD− /− nerves where mPTP is inhibited (and axonal
desintegration is delayed) at 2 dpi, correlated with the
morphological data observed (Figure 3). The molecular data
presented here therefore supports the notion that inhibition of
several metabolic pathways collectively contribute to the
neuroprotective effect demonstrated in CypD− /− mice
(Figures 10c–e).
Our unbiased approach identified multiple complex mole-
cular cascades originating from non-neuronal autonomous
glial cell processes, and then proceeding via the neuronal
Figure 8 Schwann cell fragment axons by a cytokinesis-like mechanism. (a) Teased fibers fromWT mice sciatic nerves from control conditions and at 2 dpi, immunostained for
Anillin (green), actin (using rhodamine-conjugated phalloidin, red) and nuclei (using Dapi, blue). In control conditions, Anillin is located in the peri-nuclear region (right panel), along
the SC cytoplasm known as Cajal bands. At 2 dpi, Anillin is expressed in the nucleus and at the ends of myelin ovoids. Scale bar, 20 μm. (c) Teased fibers from shRNA-
electroporated nerves at 2 dpi GFP (green) expression is a reporter for electroporation. Control shRNA-treated nerves (shScramble, left panel) or shAnillin (right panel)
immunostained for Anillin (red). Scale bar, 20 μm. (d) Quantification of Anillin expression by immunofluorescent intensity in teased fibers electroporated with the different constructs.
A significant decrease in protein expression is found in SC electroporated with shAnillin (shAni) compared with shScramble-electroporated fibers (shSc, n= 5 mice per group; 30
fibers per group; *Po0.05 by Student’s t-test compared with shScramble; error bars indicate S.E.M.). (e) Teased fibers from nerves electroporated with shScramble (green, left
panel) or shAnillin (green, right panel) and co-stained with neurofilament (Nf-H, red). Anillin knockdown strongly inhibit axonal fragmentation compared with control fibers. Scale bar,
20 μm. (f) Quantification of axonal fragmentation at 2 dpi in nerves electroporated with the indicated constructs (n= 5 per group; 30 fibers per group; *Po0.05 by Student’s t-test
compared with shScramble; error bars indicate S.E.M.). (g) Teased fibers immunostained for Ki67 (green), actin (red) and nuclei (blue) showing the absence or the different
subcellular localization of Ki67 expression. (h) Quantification of Ki67 localization from teased fiber as in panel G. Ki67 expression is absent in control and 2 dpi fibers, to start in a
peri-nuclear sub-localization at 2 dpi and 4 dpi and in a nuclear localization at 7 dpi (n= 3 mice per group; between 80 and 100 fibers per group; *Po0.05 by Student’s t-test
compared with control; error bars indicate S.E.M.). (i) Cdc2 protein expression at different times after nerve injury. Protein expression begins at 4 dpi and reaches a peak at 7 dpi
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axon. This is a novel notion, as it is generally accepted that
destruction of the axon is regulated by neuronal intrinsic
processes. However, the data generated here point to a
collaborative effort, a sort of cellular euthanasia. Moreover,
these results suggest that activation of SC axokinesis could
lead to axonal fragmentation, indirectly impacting neuronal
function, a phenomenon that should be evaluated in neuro-
degenerative conditions, in which axonal degeneration has
been demonstrated as an early event of the pathology.
Materials and Methods
Animals. Adult (12 weeks, 20–25 grs) Ppif− /− (CypD− /−) KO, Thy1-YFP, Wlds
and wild-type C57/BL6J mouse strains were used.26,32 Experiments with animals
followed protocols approved by the Institutional Animal Care and Use Committees
and complied National Institutes of Health guidelines.
Sciatic nerve injury and intraneural drug treatments. The animals
were anesthetized with 2’2’2-tribromoethanol (Sigma, St. Louis, MO, USA, 330 mg/
kg) and the right sciatic nerve was exposed between the hipbone and the Notch and
crushed 3 times for 5 s each with a Nº5 Dumont forceps. In all conditions, the nerve
was dissected 2 or 4 days post injury. For drug treatments, intraneural injections
were made in the tibial fascicle of the sciatic nerve. For most drugs the treatment
was performed daily starting from the day of crush. For ActD, the drug was injected
6 and 3 days before the nerve crush. The following drugs and concentrations were
used: Actinomysin D (Calbiochem, San Diego, CA, USA, #114666, 0,2 μg/μl), PD
0325901 (Cayman, Ann Arbor, MI, USA, #13034, 2 μM), Cytochalasin D (Sigma,
#C6637, 2 μg/ml), Blebbistatin (Sigma, #B0560, 500 μM), Ciclosporin A (LC
Laboratories, Woburn, MA, USA, #C6000, 5 μM) and Y-27632 (Sigma, #Y0503,
50 μM).
Teased fiber IF. For IF analysis, nerves were fixed by immersion in 4%
paraformaldehyde in 1 × PBS (pH 7.4) for 1 h, followed by three 10 min washes in
1 × PBS. Under a dissecting microscope, the perineurium was removed and fibers
were teased in TESPA-coated slide and stored at − 20 degrees. Teased fibers were
placed directly into pre-chilled (−20ºC) acetone for 20 min at − 20 ºC. After air dry
the acetone, slides were blocked/permeabilized in 0.1% Triton X-100, 5% fish skin
gelatin (Sigma, G7765) in 1 × PBS 1 h at room temperature (RT) and incubated
Figure 9 Axonal fragmentation is ROCK dependent. (a) Teased fibers from WT mice sciatic nerves immunostained for neurofilament (Nf-H, green) and stained for actin
filaments using phalloidin (red). Y-27632 (50 μM) treatment inhibits axonal fragmentation at 2 dpi and axonal disintegration at 4 dpi Scale bar, 20 μm. (b) Quantification of the
percentage of unfragmented fibers (intact fibers) after treatment from teased fibers as shown in (a). Only at 2 dpi, Y-27632 treatments significantly inhibit fiber fragmentation (n= 3
mice per group; between 80 and 100 fibers per group; *Po0.05 by Student’s t-test compared with 2 or 4 dpi vehicle; error bars indicate S.E.M.). (c) Percentage of axonal
occupancy per fiber (Ax. Occ/Fib.) measured from teased fibers in vehicle-injected nerves and after Y-27632 injection. At 4 dpi, the disintegration of axons is significantly inhibited
after drug treatments (n= 3 mice per group; 30 fibers per group were analyzed; *Po0.05 by Student’s t-test compared with 2 or 4 dpi vehicle; error bars indicate
S.E.M.). (d and e) ASL distribution at 2 and 4 dpi from vehicle and Y-27632-injected nerves. Drug treatment inhibits the reduction of ASL after injury. Color-coded arrows indicate
the mean value in each set of data (n= 3 mice per group; between 90 and 120 ALS were measured per group; *Po0.05 by Student’s t-test compared with 2 or 4 dpi vehicle).
(f) MRLC protein expression at different times after nerve injury
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overnight with primary antibodies in the same solution at 4 °C using a humid
chamber. Next day fibers were washed in 1 × PBS three times 10 min and
incubated in secondary antibodies for 2 hours at RT. Slides were washed 3 × 10 min
in 1 × PBS and mounted in Fluoromount (EMS, Hatfield, PA, USA, #17984).
Electron microscopy. For EM analyses, nerves were fixed overnight by
immersion in 2.5% glutaraldehyde, 0.01% picric acid, 0.1 M cacodylate buffer, pH
7.4. Nerves were rinsed in the same buffer, immersed in 1% OsO4 for 1 h followed
by in block incubation with 2% uranyl acetate for 2 hours. Nerves were dehydrated
with a graded series of ethanol, propylene oxide and infiltrated with Epon (Ted Pella
Inc. # 18012). One micron thick semithin sections from the middle of the nerve were
stained with 1% toluidine blue for light microscopy. Ultra thin sections from the same
nerve were contrasted with 1% uranyl acetate and lead citrate. Grids were
examined with a Philips Tecnai 12 electron microscope operated at 80 kV.
Primary/secondary antibodies and dyes. The following antibodies were
used: rabbit anti-neurofilament heavy chain (Sigma, #N4142) at 1:1000, rabbit anti-
myelin basic protein (Sigma, #M3821) at 1:500; rabbit anti-p75NTR (Millipore, #07-
476) at 1:300; goat anti-anillin (Santa Cruz, #sc-54859) at 1:50; rabbit anti-myosin
IIA (OneWorld, #bs_8564R) at 1:50; goat anti-rabbit Alexa Fluor 488 (Invitrogen,
#A11034) at 1:1000; goat anti-rabbit Alexa Fluor 546 (Invitrogen, #A11035) at
1:1000; rabbit anti-goat Alexa Fluor 488 (Invitrogen, #A11078) at 1:1000 and
Rhodamine-conjugated Phalloidin (Sigma, #P1951) at 1:1000.
In vivo shRNA experiment. shRNA construct were purchased from Biosettia
(San Diego, CA, USA). The following sequences for the Anillin gene were used:
shAnillin-1: 5′-AAAAGCATCTGCTAGCATCAATATTGGATCCAATATTGATGCTAGC
AGATGC-3′, shAnillin-2: 5′-AAAAGCAAGCATCTAGAAACCAATTGGATCCAATTG
GTTTCTAGATGCTTGC-3′, shAnillin-3: 5′-AAAAGCGCTCAATATCTCTTCAATTGG
ATCCAATTGAAGAGATATTGAGCGC-3′, shAnillin-4:
5′-AAAAGCTCTGACATTTCCTACTATTGGATCCAATAGTAGGAAATGTCAGAGC
-3′ and Scramble: 5′-AAAAGCTACACTATCGAGCAATTTTGGATCCAAAATTGCTC
GATAGTGTAGC-3′. The constructs were amplified and purified with an AxiPrep
Plasmid Miniprep Kit (Axygen, Union City, CA, USA, AP-MN-P-250), injected one
microliter of the four shAnillin together (final concentration 0.73 μg/μl) or Scramble
(0.72 μg/μl) in the nerve and then electroporated using a Super Electroporator NEPA
21 Type II (NepaGene, Chiba, Japan) with the following conditions: Poring pulse 50 V,
5 ms length, 50 ms interval, 2 pulses, 7 times per nerve. After 4 days, the injected
nerves were damage and fibers analyzed 2 days post injury.
DRG explant cultures, IF and analysis. Dorsal root ganglia (DRGs) were
obtained from Sprague Dawley rat embryos (E16). Briefly, DRGs were dissected
and placed on coverslips coated with rat tail collagen (Invitrogen). DRGs were
maintained in Neurobasal medium (Invitrogen) supplemented with 2% B27
(Invitrogen), 2 mM L-glutamine, 50 ng/ml human nerve growth factor (NGF;
Invitrogen) and 1% penicillin–streptomycin, 4 μM Aphidicolin and 7.5 μg/ml 5-fluoro-
2- deoxyuridine. The mixture of aphidicolin and fluoro-2-deoxyuridine inhibits
proliferation of Schwann cells by inhibition of DNA polymerase. DRGs were cultured
for 7 d at 37 °C and 5% CO2. At day 7, ganglia were excised using a micropipette
tip. This procedure eliminated all neuronal somas from the ganglia. The following
drugs were used: Actinomycin D 1 ng/ml, PD0325901 0.1 μM, Citochalasyn-D 1 μg/
ml, Blebbistatin 100 μM and Y-27632 10 μM. The degeneration index was based on
the ratio of the areas of fragmented axons versus total axonal area. Degenerated
axon fragments were detected using the particle analyzer algorithm of NIH ImageJ,
and the total fragmented axon area versus total axonal area was used to estimate a
degeneration index.
For IF analyses, DRGs were fixed with 4% PFA for 30 min at room temperature,
followed by 2 h blocked/permeabilized in 1% Triton X-100, 5% fish skin gelatin
(Sigma) in PBS. Cells were then stained with rabbit anti-neurofilament heavy chain
(NFH; catalog #N4142; Sigma-Aldrich) at 1:1000 overnight at 4 °C, washed three
times in PBS for 5 min, and incubated with fluorescently labeled secondary antibody
(Alexa546; Life Technologies) for 2 h at room temperature. Cells were washed in PBS
and mounted in Fluoromount.
Figure 10 Bioinformatic analysis of proteomic data at 2 dpi reveals molecular perturbations correlating with the intrinsic axonal mediated destruction cascades previously
reported. (a) Table illustrating expected morphological hallmarks, which can be used as a filtering guide at 2 dpi (b) Heat map highlighting expression trends following filtering
criteria at 2 dpi, that is differential expression between WTand CypD− /− (c) DAVID enrichment analysis of candidates following filtering highlights mitochondria and bioenergetics
cascades which correlate with the known structural alterations present in WT nerves at 2 dpi (d,e) Canonical pathway alterations correlate to DAVID enrichment and highlight
downregulation in a broad range of mitochondrial associated metabolic processes which are in agreement with published data suggesting that factors such as cytochrome c
release from complex IV is inhibited in CypD− /− vs WT nerved. (f–h) Upstream regulator predictions and biofunction analysis suggest the inhibition of IGF, insulin and oxidative
metabolic regulated processes (respectively) in CypD− /− relative to WT nerves at 2 dpi
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Data analysis and statistics. All slides were photographed in an
epifluorescence Olympus microscope (Miami, FL, USA) and analyzed for the
following parameters: Inter-incisure distance (IID), distance between two adjacent
incisures positive for phalloidin; Myelin ovoid length (MOL) the distance between the
beginning and the end of the ovoid, discriminated by bright field; axonal segment
length (ALS), labeled with neurofilament and the percentage of fragmented fiber,
quantification of intact versus fragmented fibers in bright field; axonal coverage per
fiber, the ratio between the sum of the length of all the axonal segment in one fiber
and the length fiber. Ten to 15 random pictures per slide were taken for each animal,
time and treatment. All measurements were perform using the Image J software and
calibrated microscope images. All the fibers in each pictures (from 2 to 15) were
quantified for each measurements. Statistical analysis was made using Student’s
t-test and one way ANOVA plus Bonferroni post hoc test.
Label-free proteomics. The experimental design for label-free proteomics
experiments was based on previous similar analyses33–35 and is shown in
Figure 5a. Protein isolated from preparations of WT, CypD− /− and Wlds mouse
sciatic nerve were extracted in SDT lysis buffer containing 100 mM Tris-HCl (pH
7.6), 4% (W/V) Sodium dodecyl sulfate (VWR) and 0.1 M d/l-dithiothreitol (Sigma).
Each genotype was examined at three time points — 0, 1 and 2 dpi with 4 mice at
each time point per condition. For efficient protein extraction, lysates homogenized
in SDT buffer in a MACS Dissociator tube. Protein concentration was then
determined using BCA assay and confirmed by total protein gel as previously
described.36 For label-free proteomic analysis, single aliquots for each time point
within each condition were prepared (100–25 μg per mouse) and were processed
through FASP (filter-aided sample preparation) involving buffer exchange to 8 M
urea and alkylation with 50 mM iodoacetamide prior to a double digestion with
trypsin (Roche, sequencing grade), initially for 4 h, then overnight at 30 °C. Trypsin-
digested peptides were separated using an Ultimate 3000 RSLC (Thermo Fisher
Scientific, Waltham, MA, USA) nanoflow LC system. Using an ESI Easy Spray
source at 50 °C, technical replicates (3 ×∼ 2.5 μg) of each ‘pooled’ sample were
loaded with a constant flow of 5 μl/min onto an Acclaim PepMap100 nanoViper C18
trap column (100 μm inner diameter, 2 cm length; Thermo Scientific). After trap
enrichment, peptides were eluted onto an Acclaim PepMap RSLC nanoViper, C18
column (75 μm, 50 cm; Thermo Scientific) with a linear gradient of 2–40% solvent B
(80% acetonitrile with 0.08% formic acid) over 128 min with a constant flow of
300 nl/min. The HPLC system was coupled to a linear ion trap Orbitrap hybrid mass
spectrometer (LTQ-Orbitrap Velos Pro, Thermo Scientific) via a nanoelectrospray
ion source (Thermo Scientific). The spray voltage was set to 1.6 kV, and the
temperature of the heated capillary was set to 250 °C. Full-scan MS survey spectra
(m/z 335–1800) in profile mode were acquired in the Orbitrap with a resolution of
60,000 after accumulation of 1,000,000 ions. Lock mass was set at 445.120024.
The 15 most intense peptide ions from the preview scan in the Orbitrap were
fragmented by collision-induced dissociation (normalized collision energy, 35%;
activation Q, 0.250; and activation time, 10 ms) in the LTQ after the accumulation of
10,000 ions. Dynamic exclusion parameters were set as follows: repeat count, 1;
repeat duration, 30 s; exclusion list size, 500; exclusion duration, 45 s; exclusion
mass width, plus/minus 10 p.p.m. (relative to reference mass). Maximal filling times
were 1000 ms for the full scans and 150 ms for the MS/MS scans. Precursor ion
charge state screening was enabled, and all unassigned charge states as well as
singly charged species were rejected. The lock mass option was enabled for survey
scans to improve mass accuracy. Data were acquired using the Xcalibur software
(Thermo Fisher Scientific, Waltham, MA, USA).
The raw data was then imported to Progenesis QI for label-free differential analysis
and quantification of relative abundance ratios. A pool of all samples was run per
triplicate as quality control samples (QC). Runs were aligned to a QC sample for the
identification of common features. After the peak picking across all data files,
identified peptides with P value 40.05 (one way ANOVA) and powero0.8 were
filtered in order to reduce excess of unreliable data. Next, peptide information was
exported and used for peptide sequence identification and protein assignment with
Mascot using the Uniprot mouse database. Protein identifications were then imported
back to Progenesis for further analysis and filtering. 47 418 search hits were imported
and assigned to peptide ions, which was equivalent to a total of 1839 proteins. For
further analysis, however, only proteins identified by≥ 2 peptides and P valueo0.05
were used (1067 proteins, Supplementary Table 1).
Proteomic data processing. Due to the heterogeneity of the whole nerve
cellular homogenates further filtering steps were required to unravel the contribution
of each cell types to the molecular mechanisms of axonal fragmentation or axonal
degeneration (Supplementary Figure 3).
Fragmentation was studied at 1 dpi (See Materials and Methods, Figure 5) and its
mechanisms was unravel by enriching for proteins that are more likely to be
associated with the early axonal fragmentation cascades (see Results and
Figure 5b). As fragmentation occurs in both WT and CypD− /− nerves, but not in
Wlds at early stages, proteins were selected, which demonstrate conserved protein
expression alterations between WT and CypD− /−, but which differ in Wlds at 1 dpi
Specifically, we are seeking to elucidate the molecular cascades/immediate early
responses occurring between 0 and 1 dpi in WT nerves and how expression in the
CypD− /− and Wlds mutants compare in relation to those processes (i.e., relative to
WT 1 dpi). Of the 1064 proteins identified in all samples at all time points, 154 proteins
accomplish this criteria and were utilized in this section (Supplementary Figure 3A,
Figure 6b and Supplementary Table 2).
Internal axonal mechanisms of destruction were studied at 2 dpi (See Figure 10).
In order to enrich our samples for axonal dependent cascades rather than SC-
associated ones (see above), we filtered the data for proteins displaying differential
expression between WT and CypD− /− nerve isolates and overlap with clusters
related to mitochondria in the WT time-course analysis (Figures 5c and d). Of the
1064 proteins identified in all samples at all time points, 190 met this filtering criteria
(Supplementary Figure 3B, Figure 10b and Supplementary Table 3).
In silico analysis
BioLayout Express 3D: this software incorporates a complex pattern
recognition algorithm, which allows grouping of data by expression profile
independent of protein function or identification information. This software was
developed in the Roslin Institute and further information on the use of this program
and free access can be found in http://www.biolayout.org.
Analysis of WT proteomic data using biolayout allows clustering of protein
abundance by temporal expression profile (Figures 5c and d). In this display each
sphere represents an individual protein and its color and proximity to its neighbor
indicates the similarity in protein expression (through time). Clusters (groupings of
proteins delineated by color) can be further analyzed for cell type or functional
association with other in silico tools – see below (Figure 5d).
Enrichment analysis. To obtain an indication of the level of sample
enrichment afforded the data was processed using The Database for Annotation,
Visualization and Integrated Discovery (DAVID) software (available at http://david.
abcc.ncifcrf.gov). David provides a relatively comprehensive set of functional
annotation tools for large data set interpretation.37,38
Ingenuity pathway analysis (IPA) software: This is a ‘hand–curated’
database that analyses and identifies statistically significant functional candidate
associations, based on known interactions and biological functions reported in the
published literature. This information is derived from peer reviewed publications and
can be traced back to data at the genomic, transcriptomic and/or proteomic level.
Functional categorization, function and/or predicted activations are therefore an
indication of how data (in this case proteomic identifications and abundance) sits within
the context of the known ‘interactome’. Canonical pathway tools were used for the
identification of known pathways within these data sets. Pathways from IPA library of
canonical pathways were ranked according to significance of the association between
our data sets and the known canonical pathway members. Details about how these are
calculated can be found in the published literature.39 Data imported into IPA were
subjected to a 1.2-fold filter and searched against only those database entries, which
were derived from experimentally observed data (i.e., not predicted/homology derived).
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